CMPS - Podcast - Post-Frenzy Psychedelics Investing And Reclaiming The Right To Pursue Happiness With Zappy Zapolin: '2024 Is When It Goes Mainstream' | Benzinga
Welcome to a new episode of our Benzinga Psychedelics Podcast, this time joined by business trendspotter and "psychedelics concierge" Zappy Zapolin. He has served in a range of positions, from advisor to psychedelic companies like KetaMD – acquired by Braxia Scientific (OTC:BRAXF) and chief visionary officer to Psycheceutical Bioscience (OTC:BWVI). Now Zappy is launching guided psychedelic retreat experiences.
The conversation runs through a diverse array of topics – a mere reflection of Zappy's innate curiosity and vital involvement in the space. Expect everything from investment outlooks for 2024 and beyond, psychedelic’s relationship with traditional pharma and to whom we should turn for important info in the space. The podcast is a timely reflection of the evolution psychedelics have undergone over the past several years, keeping in mind the pandemic's effect on the acknowledgment of mental health issues. It also takes listeners into a brand new ketamine retreat in Malibu Hills.